Literature DB >> 19868246

EXPERIMENTAL TRYPANOSOMIASIS: ITS APPLICATION IN CHEMOTHERAPEUTIC INVESTIGATIONS.

L Pearce1, W H Brown.   

Abstract

Year:  1918        PMID： 19868246      PMCID： PMC2126266          DOI： 10.1084/jem.28.2.109

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


× No keyword cloud information.
  5 in total

1.  THERAPEUTIC ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID (TRYPARSAMIDE) UPON EXPERIMENTAL INFECTIONS OF TRYPANOSOMA RHODESIENSE.

Authors:  L Pearce; W H Brown
Journal:  J Exp Med       Date:  1921-01-31       Impact factor: 14.307

2.  CHEMOTHERAPY OF TRYPANOSOME AND SPIROCHETE INFECTIONS : BIOLOGICAL SERIES. II. THE THERAPEUTIC ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID IN EXPERIMENTAL TRYPANOSOMIASIS OF MICE, RATS, AND GUINEA PIGS.

Authors:  L Pearce; W H Brown
Journal:  J Exp Med       Date:  1919-10-31       Impact factor: 14.307

3.  CHEMOTHERAPY OF TRYPANOSOME AND SPIROCHETE INFECTIONS : BIOLOGICAL SERIES. III. THE THERAPEUTIC ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID IN EXPERIMENTAL TRYPANOSOMIASIS OF RABBITS.

Authors:  L Pearce; W H Brown
Journal:  J Exp Med       Date:  1919-10-31       Impact factor: 14.307

4.  EXPERIMENTAL STUDIES WITH A SPIRAL ORGANISM FOUND IN A WILD RAT AND IDENTICAL WITH THE ORGANISM CAUSING RAT-BITE FEVER : SECOND PAPER.

Authors:  H Mooser
Journal:  J Exp Med       Date:  1925-09-30       Impact factor: 14.307

5.  ETIOLOGY OF YELLOW FEVER : XII. CHEMOTHERAPY VERSUS SEROTHERAPY IN EXPERIMENTAL INFECTION WITH LEPTOSPIRA ICTEROIDES.

Authors:  H Noguchi
Journal:  J Exp Med       Date:  1920-09-30       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.